L, C., Y, C., W, L., S, Z., & Z, Z. (2026). Immune checkpoint inhibitor-induced bullous pemphigoid: A systematic review of clinical characteristics and outcomes based on case reports. Frontiers in immunology, 17, 1745011. https://doi.org/10.3389/fimmu.2026.1745011
Chicago Style (17th ed.) CitationL, Chang, Cui Y, Lu W, Zhao S, and Zhuo Z. "Immune Checkpoint Inhibitor-induced Bullous Pemphigoid: A Systematic Review of Clinical Characteristics and Outcomes Based on Case Reports." Frontiers in Immunology 17 (2026): 1745011. https://doi.org/10.3389/fimmu.2026.1745011.
MLA (9th ed.) CitationL, Chang, et al. "Immune Checkpoint Inhibitor-induced Bullous Pemphigoid: A Systematic Review of Clinical Characteristics and Outcomes Based on Case Reports." Frontiers in Immunology, vol. 17, 2026, p. 1745011, https://doi.org/10.3389/fimmu.2026.1745011.